TY - JOUR
T1 - Associations between fruit intake and risk of diabetes in the AusDiab cohort
AU - Bondonno, Nicola P.
AU - Davey, Raymond J.
AU - Murray, Kevin
AU - Radavelli-Bagatini, Simone
AU - Bondonno, Catherine P.
AU - Blekkenhorst, Lauren C.
AU - Sim, Marc
AU - Magliano, Dianna J.
AU - Daly, Robin M.
AU - Shaw, Jonathan E.
AU - Lewis, Joshua R.
AU - Hodgson, Jonathan M.
N1 - Funding Information:
The AusDiab study, initiated and coordinated by the International Diabetes Institute, and subsequently coordinated by the Baker Heart and Diabetes Institute, gratefully acknowledges the support and assistance given by: A. Allman, B. Atkins, S. Bennett, A. Bonney, S. Chadban, M. de Courten, M. Dalton, D. Dunstan, T. Dwyer, H. Jahangir, D. Jolley, D. McCarty, A. Meehan, N. Meinig, S. Murray, K. O?Dea, K. Polkinghorne, P. Phillips, C. Reid, A. Stewart, R. Tapp, H. Taylor, T. Welborn, T. Whalen, F. Wilson, and P. Zimmet. Also, for funding or logistical support, we are grateful to the National Health and Medical Research Council (NHMRC grant No. 233200), Australian Government Department of Health and Ageing, Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, AstraZeneca, Bristol-Myers Squibb, City Health Centre-Diabetes Service-Canberra, Department of Health and Community Services?Northern Territory, Department of Health and Human Services-Tasmania, Department of Health-New South Wales, Department of Health?Western Australia, Department of Health-South Australia, Department of Human Services?Victoria, Diabetes Australia, Diabetes Australia Northern Territory, Eli Lilly Australia, the Estate of the Late Edward Wilson, GlaxoSmithKline, the Jack Brockhoff Foundation, Janssen-Cilag, Kidney Health Australia, the Marian & FH Flack Trust, Menzies Research Institute, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Pfizer Pty Ltd, Pratt Foundation, Queensland Health, Roche Diagnostics Australia, Royal Prince Alfred Hospital, Sydney, Sanofi Aventis, Sanofi-Synthelabo, and the Victorian Government?s OIS Program. Financial Support: This work was supported by a National Health and Medical Research Council (NHMRC) Early Career Fellowship (grant No. APP1159914 to N.P.B.), Australia; an NHMRC of Australia Emerging Leadership Investigator Grant (ID No. 1172987 to L.C.B.); a National Heart Foundation of Australia Post-Doctoral Research Fellowship (No. ID 102498); a National Heart Foundation of Australia Future Leader Fellowship (No. ID 102817 to J.R.L.); an NHMRC of Australia Senior Research Fellowship (grant No. APP1116937 to J.M.H.); and an NHMRC of Australia Investigator Grant (grant No. APP1173952 to J.E.S.).
Publisher Copyright:
© The Author(s) 2021.
PY - 2021/10/1
Y1 - 2021/10/1
N2 - Context: Fruit, but not fruit juice, intake is inversely associated with type 2 diabetes mellitus (T2DM). However, questions remain about the mechanisms by which fruits may confer protection. Objective: The aims of this work were to examine associations between intake of fruit types and 1) measures of glucose tolerance and insulin sensitivity and 2) diabetes at follow-up. Methods: Among participants of the Australian Diabetes, Obesity and Lifestyle Study, fruit and fruit juice intake was assessed by food frequency questionnaire at baseline. Associations between fruit and fruit juice intake and 1) fasting plasma glucose, 2-hour postload plasma glucose, updated homeostasis model assessment of insulin resistance of β-cell function (HOMA2-%β), HOMA2 of insulin sensitivity (HOMA2-%S), and fasting insulin levels at baseline and 2) the presence of diabetes at follow-up (5 and 12 years) were assessed using restricted cubic splines in logistic and linear regression models. Results: This population of 7675 Australians (45% males) had a mean ± SD age of 54 ± 12 years at baseline. Total fruit intake was inversely associated with serum insulin and HOMA2-%β, and positively associated with HOMA2-%S at baseline. Compared to participants with the lowest intakes (quartile 1), participants with moderate total fruit intakes (quartile 3) had 36% lower odds of having diabetes at 5 years (odds ratio, 0.64; 95% CI, 0.44-0.92), after adjusting for dietary and lifestyle confounders. Associations with 12-year outcomes were not statistically significant. Conclusion: A healthy diet including whole fruits, but not fruit juice, may play a role in mitigating T2DM risk.
AB - Context: Fruit, but not fruit juice, intake is inversely associated with type 2 diabetes mellitus (T2DM). However, questions remain about the mechanisms by which fruits may confer protection. Objective: The aims of this work were to examine associations between intake of fruit types and 1) measures of glucose tolerance and insulin sensitivity and 2) diabetes at follow-up. Methods: Among participants of the Australian Diabetes, Obesity and Lifestyle Study, fruit and fruit juice intake was assessed by food frequency questionnaire at baseline. Associations between fruit and fruit juice intake and 1) fasting plasma glucose, 2-hour postload plasma glucose, updated homeostasis model assessment of insulin resistance of β-cell function (HOMA2-%β), HOMA2 of insulin sensitivity (HOMA2-%S), and fasting insulin levels at baseline and 2) the presence of diabetes at follow-up (5 and 12 years) were assessed using restricted cubic splines in logistic and linear regression models. Results: This population of 7675 Australians (45% males) had a mean ± SD age of 54 ± 12 years at baseline. Total fruit intake was inversely associated with serum insulin and HOMA2-%β, and positively associated with HOMA2-%S at baseline. Compared to participants with the lowest intakes (quartile 1), participants with moderate total fruit intakes (quartile 3) had 36% lower odds of having diabetes at 5 years (odds ratio, 0.64; 95% CI, 0.44-0.92), after adjusting for dietary and lifestyle confounders. Associations with 12-year outcomes were not statistically significant. Conclusion: A healthy diet including whole fruits, but not fruit juice, may play a role in mitigating T2DM risk.
KW - 2-hour postload plasma glucose
KW - Fasting insulin levels
KW - Fasting plasma glucose
KW - HOMA2 of insulin sensitivity (HOMA2-%S)
KW - HOMA2 of β-cell function (HOMA2-%β)
UR - http://www.scopus.com/inward/record.url?scp=85110269124&partnerID=8YFLogxK
U2 - 10.1210/clinem/dgab335
DO - 10.1210/clinem/dgab335
M3 - Article
C2 - 34076673
AN - SCOPUS:85110269124
SN - 0021-972X
VL - 106
SP - E4097-E4108
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 10
ER -